Interferon-alfa2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.

被引：0
|
作者：
Shakil, AO
McGuire, B
Crippin, JS
Canjeevaram, HS
Teperman, L
Gish, RG
Kwo, P
Wright, TL
Brass, C
Balan, V
Demetris, J
Rakela, J
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Alabama, Birmingham, AL USA
[3] Baylor Univ, Dallas, TX USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] New York Med Ctr, New York, NY USA
[6] Calif Pacific Med Ctr, San Francisco, CA USA
[7] Indiana Univ, Indianapolis, IN 46204 USA
[8] Univ Calif San Francisco, San Francisco, CA 94143 USA
[9] Integrated Therapeut Grp Inc, Kenilworth, NJ USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
221
引用
收藏
页码：216A / 216A
页数：1
相关论文
共 50 条
  • [41] Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C
    Soza, A
    Everhart, JE
    Ghany, MG
    Doo, E
    Heller, T
    Promrat, K
    Park, Y
    Liang, TJ
    Hoofnagle, JH
    HEPATOLOGY, 2002, 36 (05) : 1273 - 1279
  • [42] Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing
    Neff, GW
    O'Brien, CB
    Cirocco, R
    Montalbano, M
    de Medina, M
    Ruiz, P
    Khaled, AS
    Bejarano, PA
    Safdar, K
    Hill, MA
    Tzakis, AG
    Schiff, ER
    LIVER TRANSPLANTATION, 2004, 10 (05) : 595 - 598
  • [43] Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection
    Beckebaum, S
    Cicinnati, VR
    Karliova, M
    Dirsch, O
    Erim, Y
    Frilling, A
    Malago, M
    Broelsch, CE
    Treichel, U
    Gerken, G
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) : 2080 - 2081
  • [44] Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, J
    Weaver, L
    Schafer, DF
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) : 3042 - 3044
  • [45] Impact of pegylated interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MS
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 244A - 244A
  • [46] Outcomes of liver transplant recipients with hepatitis C receiving interferon/ribavirin treatment
    Smallwood, GA
    Devine, R
    Lehneman, J
    Connor, K
    Stieber, AC
    Heffron, TG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 500 - 500
  • [47] Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alfa interferon.
    Herrera, J
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [48] Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
    Poynard, Thierry
    Colombo, Massimo
    Bruix, Jordi
    Schiff, Eugene
    Terg, Ruben
    Flamm, Steven
    Moreno-Otero, Ricardo
    Carrilho, Flair
    Schmidt, Warren
    Berg, Thomas
    McGarrity, Thomas
    Heathcote, E. Jenny
    Goncales, Fernando
    Diago, Moises
    Craxi, Antonio
    Silva, Marcelo
    Bedossa, Pierre
    Mukhopadhyay, Pabak
    Griffel, Louis
    Burroughs, Margaret
    Brass, Clifford
    Albrecht, Janice
    GASTROENTEROLOGY, 2009, 136 (05) : 1618 - 1628
  • [49] Interferon alfa-2a in combination with ribavirin and amantadine (triple therapy) in hepatitis C patients with previous non-response or relapse to interferon alfa and ribavirin combination therapy.
    Reichard, O
    Lindahl, K
    Schvarcz, R
    Uhnoo, I
    Shev, S
    Carlsson, T
    Wejstal, R
    HEPATOLOGY, 1999, 30 (04) : 372A - 372A
  • [50] Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C
    Yeh, Frank
    Gordon, Fredric D.
    FUTURE VIROLOGY, 2007, 2 (06) : 553 - 563
12345